PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 77 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,436,245 | -35.2% | 138,500 | -10.5% | 0.00% | – |
| Q2 2023 | $2,214,846 | +537.2% | 154,668 | +217.7% | 0.00% | – |
| Q1 2023 | $347,583 | -58.1% | 48,681 | -34.2% | 0.00% | – |
| Q4 2022 | $830,414 | +30.8% | 74,012 | +29.1% | 0.00% | – |
| Q3 2022 | $635,000 | +43.7% | 57,342 | +9.5% | 0.00% | – |
| Q2 2022 | $442,000 | +14.5% | 52,372 | +84.8% | 0.00% | – |
| Q1 2022 | $386,000 | -42.5% | 28,337 | -16.9% | 0.00% | – |
| Q4 2021 | $671,000 | +191.7% | 34,117 | +376.3% | 0.00% | – |
| Q3 2021 | $230,000 | -84.3% | 7,163 | -83.7% | 0.00% | – |
| Q4 2020 | $1,464,000 | +624.8% | 44,078 | +579.0% | 0.00% | – |
| Q4 2019 | $202,000 | – | 6,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |